Grifulvin V

Prodotti simili

Diflucan

Prezzo da €56.84

Vedi

Fulvicin

Prezzo da €21.21

Vedi

Lotrisone

Prezzo da €34.78

Vedi

Nizoral

Prezzo da €50.90

Vedi

Mentax

Prezzo da €40.72

Vedi

Gyne-Lotrimin

Prezzo da €33.93

Vedi

I’ve been prescribing Grifulvin V for over two decades now. I remember the first time I used it—a young farmer, 22 years old, presented with these massive, boggy plaques on his forearm. The dermatology resident called it kerion. The kid was in pain, embarrassed, and had been on clotrimazole for six weeks with zero improvement. We did a KOH prep right there in the clinic. Positive for dermatophytes. I wrote him a script for Grifulvin V, 500 mg daily, micronized. Told him to take it with a fatty meal—whole milk, eggs, whatever. Two months later, his arm was clear. No scarring. He went back to work. That case sold me on this drug. It’s old, sure. But for certain things, nothing else works as well.

Grifulfin V (griseofulvin, micronized) is an oral antifungal agent. It’s not a first-line drug anymore for most dermatophyte infections—terbinafine and azoles have largely replaced it due to shorter treatment courses and better tolerability. But here’s the thing: Grifulvin V has a unique mechanism. It binds to tubulin, disrupts mitotic spindle formation, and inhibits fungal cell division. It’s fungistatic, not fungicidal. That means you need longer courses. But it also means it’s remarkably safe for long-term use in kids. I’ve used it for tinea capitis in children for 8-12 weeks without a single liver enzyme elevation that required stopping. You can’t say that about terbinafine in the same population.

Indications and Use Cases

The primary indication is dermatophyte infections of the skin, hair, and nails caused by species of Microsporum, Epidermophyton, and Trichophyton. It’s not effective against Candida or Malassezia. I’ve seen practitioners try it for tinea versicolor—don’t. It doesn’t work. You’ll just waste two months and frustrate the patient.

Tinea capitis is where Grifulvin V still shines. In pediatric populations, especially for Microsporum canis infections, it’s the drug of choice in many guidelines. The micronized formulation gives better absorption. We used to use the ultramicronized version, but it’s been harder to find. The key is dosing. For children, I dose at 10-15 mg/kg/day of micronized griseofulvin. For adults, 500 mg to 1 gram daily. You have to go high enough. I’ve seen failures because people underdose. One of my colleagues—a very sharp internist—kept prescribing 250 mg daily for an adult with tinea corporis. After six weeks, no change. I bumped it to 750 mg daily with a fatty meal. Three weeks later, it was resolving. The difference is real.

For tinea pedis and tinea cruris, I rarely use it anymore. Terbinafine is faster—two weeks versus four to six. But I have patients who cannot tolerate terbinafine. Taste disturbances, GI upset, rare but real liver toxicity. For those patients, Grifulvin V is a solid alternative. It’s also dirt cheap. The generic micronized tablets cost pennies. In a system where we’re trying to keep costs down, that matters.

Mechanism of Action and Bioavailability

Griseofulvin is deposited in the keratin precursor cells. As these cells differentiate and move outward, the drug is carried to the skin, hair, and nails. It binds to newly formed keratin, making it resistant to fungal invasion. That’s why you need to treat until the infected keratin is shed. For toenails, that’s 6 to 12 months. For fingernails, 4 to 6 months. For scalp hair, 6 to 8 weeks. You can’t rush it. The drug doesn’t kill the fungus outright—it just makes the new growth inhospitable.

The micronized formulation is absorbed better than the non-micronized version. Taking it with a high-fat meal increases absorption significantly. I always counsel patients: take it with whole milk, ice cream, avocado, eggs, or fatty fish. One patient told me she ate a spoonful of peanut butter every morning with her pill. That worked perfectly. I’ve also seen people take it on an empty stomach and wonder why it didn’t work. Absorption can vary 4-fold depending on food. That’s not insignificant.

The Clinical Evidence

The evidence base is from the 1960s through the 1980s. Don’t expect modern RCTs. But the data is solid. A classic study by Kligman and Anderson in 1970 showed that griseofulvin given for 8 weeks cured 95% of tinea capitis cases in children. More recent studies, like a 2008 Cochrane review, confirmed that griseofulvin is as effective as terbinafine for tinea capitis caused by Microsporum species. For Trichophyton species, terbinafine is faster. But for Microsporum, griseofulvin remains superior.

I had a case last year. A 7-year-old girl from a local school. Outbreak of tinea capitis. Five kids infected. The school nurse was panicking. I treated three with terbinafine and two with Grifulvin V—parental preference. The two on Grifulvin V took 10 weeks to clear. The three on terbinafine cleared in 6 weeks. But the Grifulvin V kids had no side effects. One of the terbinafine kids had transient taste loss for two months. That’s rare, but it happens. The Grifulvin V kids were fine.

Dosing, Administration, and Practical Tips

The standard dosing for micronized Grifulvin V:

I usually start adults at 500 mg twice daily. For children, I use the suspension when available—125 mg per 5 mL. It tastes awful. I warn parents. Mix it with chocolate syrup or something strong. One mom used strawberry ice cream. That worked.

Contraindications and Side Effects

Grifulvin V is contraindicated in patients with porphyria, hepatocellular disease, and in pregnancy. It’s a teratogen in animals. I don’t prescribe it to women of childbearing potential without a negative pregnancy test and reliable contraception. I’ve had to have that conversation more times than I’d like. Some patients get frustrated. But I’m not taking that risk.

Side effects are generally mild. Headache is the most common—about 10-15% of patients. I tell them to take it at night. If headaches persist, I lower the dose and titrate up. GI upset—nausea, diarrhea, dyspepsia—can occur but is usually transient. Photosensitivity is a real concern. I’ve seen two cases of severe sunburn in patients on Grifulvin V who spent a day at the beach. I now counsel everyone: wear sunscreen, avoid excessive sun exposure, wear a hat. One patient ignored this and ended up with second-degree burns on his shoulders. He wasn’t happy. I wasn’t happy either.

Drug Interactions

Grifulvin V induces cytochrome P450 enzymes, particularly CYP3A4. This can reduce the efficacy of oral contraceptives. I always tell female patients to use a backup method. I’ve had one pregnancy on Grifulvin V—the patient was on birth control pills and didn’t know about the interaction. She was furious. I now document every single interaction discussion. It also reduces warfarin efficacy. I’ve had to adjust INR in a patient on chronic anticoagulation. You have to monitor.

Barbiturates reduce griseofulvin absorption. If a patient is on phenobarbital, I avoid Grifulvin V. It’s just not worth the hassle.

The Reality of Prescribing Grifulvin V Today

Here’s the honest truth: most dermatologists don’t use it anymore. It’s old. It requires long courses. The compliance is terrible. Patients don’t want to take a pill for three months for a toenail fungus. They want the new stuff—the pulsed dosing, the shorter courses. I get it. I use terbinafine first-line for most dermatophyte infections. But I keep Grifulvin V in my back pocket for specific situations: kids with tinea capitis, patients who can’t tolerate other antifungals, and cases of Microsporum canis infection.

I also use it in patients with liver disease. Griseofulvin is metabolized in the liver but has a very low rate of hepatotoxicity compared to terbinafine and ketoconazole. I’ve used it in patients with mild hepatitis C without issue. You monitor LFTs, but the risk is low.

A Case That Changed My Practice

About five years ago, I had a 45-year-old woman with recalcitrant tinea corporis. She had it on her trunk and arms for 18 months. She had tried clotrimazole, miconazole, terbinafine cream, oral terbinafine, itraconazole—everything. Each time, it would improve but never fully clear. She was miserable. Her quality of life was terrible. She couldn’t wear short sleeves. She was avoiding social situations.

I did a culture. Trichophyton rubrum. Sensitive to terbinafine in vitro. But clinically, it wasn’t working. I was stumped. I consulted a colleague—a mycologist at the university. He said, “Try Grifulvin V. Sometimes resistance is phenotypic, not genotypic. The drug works differently.” I put her on 500 mg twice daily with a fatty meal. Six weeks later, she was 80% clear. At 12 weeks, she was completely clear. She cried in my office. She had been suffering for a year and a half. A drug from the 1950s fixed her.

That case taught me something: never dismiss an old drug. The pharmaceutical industry has no incentive to promote Grifulvin V. It’s generic. It’s cheap. There’s no marketing budget. But it works. It has a unique mechanism that no other antifungal shares. For certain patients, it’s the only thing that works.

Longitudinal Follow-Up

I followed that patient for two years. No recurrence. She still takes Grifulvin V occasionally for minor flare-ups—she keeps a bottle at home. I told her to call me if she gets a rash. She hasn’t. She sends me a Christmas card every year. That’s why I do this job.

I’ve also followed several children with tinea capitis long-term. They clear, their hair grows back, and they have no lasting effects. One boy—8 years old, severe kerion—had scarring alopecia after treatment. That wasn’t the drug’s fault. The infection had already damaged the follicles. The Grifulvin V stopped the progression. His hair grew back in patches. He’s 16 now. He wears his hair short. He doesn’t care. His mom thanked me. She said, “At least it didn’t spread.”

Final Thoughts

Grifulvin V is not a miracle drug. It’s slow. It requires compliance. It has interactions. But for the right patient, it’s irreplaceable. I use it less now than I did ten years ago. But I still keep it on my formulary. I still teach residents about it. I tell them: “Don’t forget this drug. It’s old. It’s not sexy. But it can save a patient’s hair, their nails, their sanity.”

If you’re a patient reading this: talk to your doctor. Don’t demand Grifulvin V. But if you’ve failed other treatments, or if you have a child with scalp ringworm, ask about it. The evidence is there. The experience is there. It works.

And if you’re a prescriber: don’t be afraid of old drugs. The newest isn’t always the best. Sometimes the old ways are the right ways.